These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67. Altered mitochondrial dynamics and response to insulin in cybrid cells harboring a diabetes-susceptible mitochondrial DNA haplogroup. Kuo HM; Weng SW; Chang AY; Huang HT; Lin HY; Chuang JH; Lin TK; Liou CW; Tai MH; Lin CY; Wang PW Free Radic Biol Med; 2016 Jul; 96():116-29. PubMed ID: 27107769 [TBL] [Abstract][Full Text] [Related]
68. Mitochondrial Mutations in Cardiac Disorders. Lee SR; Han J Adv Exp Med Biol; 2017; 982():81-111. PubMed ID: 28551783 [TBL] [Abstract][Full Text] [Related]
69. Context-Dependent Role of Mitochondrial Fusion-Fission in Clonal Expansion of mtDNA Mutations. Tam ZY; Gruber J; Halliwell B; Gunawan R PLoS Comput Biol; 2015 May; 11(5):e1004183. PubMed ID: 25996936 [TBL] [Abstract][Full Text] [Related]
70. Accumulation of mitochondrial DNA mutations in ageing, cancer, and mitochondrial disease: is there a common mechanism? Chinnery PF; Samuels DC; Elson J; Turnbull DM Lancet; 2002 Oct; 360(9342):1323-5. PubMed ID: 12414225 [TBL] [Abstract][Full Text] [Related]
73. Deregulated Mitochondrial DNA in Diseases. Nguyen NNY; Kim SS; Jo YH DNA Cell Biol; 2020 Aug; 39(8):1385-1400. PubMed ID: 31944832 [TBL] [Abstract][Full Text] [Related]
74. Therapies targeting innate immunity for fighting inflammation in atherosclerosis. Mendel I; Yacov N; Harats D; Breitbart E Curr Pharm Des; 2015; 21(9):1185-95. PubMed ID: 25312734 [TBL] [Abstract][Full Text] [Related]
75. Subclinical Atherosclerosis in Primary Sjögren's Syndrome: Does Inflammation Matter? Bartoloni E; Alunno A; Cafaro G; Valentini V; Bistoni O; Bonifacio AF; Gerli R Front Immunol; 2019; 10():817. PubMed ID: 31110500 [TBL] [Abstract][Full Text] [Related]
76. Concise Review: Heteroplasmic Mitochondrial DNA Mutations and Mitochondrial Diseases: Toward iPSC-Based Disease Modeling, Drug Discovery, and Regenerative Therapeutics. Hatakeyama H; Goto Y Stem Cells; 2016 Apr; 34(4):801-8. PubMed ID: 26850516 [TBL] [Abstract][Full Text] [Related]
77. Fetal programming of atherosclerosis: possible role of the mitochondria. Leduc L; Levy E; Bouity-Voubou M; Delvin E Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):127-30. PubMed ID: 20053495 [TBL] [Abstract][Full Text] [Related]
78. Mitochondrial Dysfunction and DNA Damage in the Context of Pathogenesis of Atherosclerosis. Shemiakova T; Ivanova E; Grechko AV; Gerasimova EV; Sobenin IA; Orekhov AN Biomedicines; 2020 Jun; 8(6):. PubMed ID: 32570831 [TBL] [Abstract][Full Text] [Related]
79. Mitochondrial dysfunction and mitochondrial DNA mutations in atherosclerotic complications in diabetes. Chistiakov DA; Sobenin IA; Bobryshev YV; Orekhov AN World J Cardiol; 2012 May; 4(5):148-56. PubMed ID: 22655163 [TBL] [Abstract][Full Text] [Related]
80. Ageing and atherosclerosis: vascular intrinsic and extrinsic factors and potential role of IL-6. Tyrrell DJ; Goldstein DR Nat Rev Cardiol; 2021 Jan; 18(1):58-68. PubMed ID: 32918047 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]